Cortexyme Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Hi, and thank you for everyone that's listening in. I'm Stephen Sloan. I'm an associate on Tazeen Ahmad's small and mid-cap biotech team, and it's my pleasure to be with Chris Lowe, CFO of Cortexyme for the next half-hour. So, Chris, welcome, and thank you for joining.
Thanks very much. Happy to be here.
Great. Maybe just to start, for those who aren't as familiar with the Cortexyme story, could you just provide a brief background and then maybe talk about how your approach to treating neurodegenerative diseases is unique compared to some of the other competitive therapies?
Yes, absolutely, Stephen. So the Company's been in existence for about seven years or so, and about the first five years was really in stealth mode. So a lot of our research is still being shared and being published and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |